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Dendrotoxin, a Iijow mole.cular weight protein from the venom of Dendroaspis angusticeps, is known to 
be a potent convulsant that attenuates one type of voltage-sensitive K+ channel in guinea-pig hippocampus. 
A biologically active preparation of 1251-labelled dendrotoxin has been cross-linked to its high-affinity pro- 
tein acceptor in synaptic plasma membranes from rat cerebral cortex. On SDS gel electrophoresis, a complex 
with a M, of 72,000 was observed which, assuming one toxin molecule is attached, yields an apparent size 
of 65,000 for this subunit of the acceptor. Unlike dendrotoxin, low concentrations of P-bungarotoxin, 
another pre-synaptically acitve toxin, do not inhibit its labelling. 
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1. INTRODUCTION 
Neurotransmission in the nervous system is 
mediated by movement of ions through a network 
of channels, a process which governs the excitabili- 
ty of nerve cells. With the exception of voltage- 
sensitive channels for Na+ [l] and to a lesser extent 
those for Ca*+ [2], little information is available on 
the molecular properties of the several other 
varieties known to exist. Fortunately, a number of 
neurotoxins have been identified that selectively 
perturb the operation of certain types of ion chan- 
nels [ 1,3,4] and which are proving to be useful pro- 
bes for these functional macromolecules. In this 
study, dendrotoxin (DTX), a protein isolated from 
the venom of the green mamba Dendroaspis 
angusticeps, which can modulate one type of 
voltage-sensitive K+ channel [4] was used to iden- 
tify the neuronal membrane component with 
which it interacts. 
DTX is a single-chain polypeptide with a 
molecular mass of 7 kDa [5] and has extensive se- 
quence homology with the B-chain of another 
presynaptically-active toxin, fl-bungarotoxin (~3- 
BuTX) [6]. Although DTX has relatively low tox- 
* To whom correspondence should be addressed 
icity peripherally (mouse lethal dose >5OOpg), at 
the neuromuscular junction of chick biventer cer- 
vicis muscle it facilitates the release of 
acetylcholine and is antagonistic to the action of p- 
BuTX thereon [5]; likewise, evidence for phar- 
macological antagonism between ,&BuTX and tox- 
in I, a homologue of DTX from D. polylepis, was 
obtained from toxicity tests in mice [7]. DTX is 
much more lethal when administered centrally [B], 
having a profound convulsant effect owing to its 
potentiation of the release of transmitter, as shown 
electrophysiologically in hippocampal slices in 
vitro [4,9]. From recent voltage-clamp ex- 
periments, it appears that this facilitatory action is 
mediated through inhibition of the A-current [4], 
an outward K+ conductance contributed by a 
voltage-sensitive K+ channel [lo]. Consistent with 
this specific and novel action, saturable binding 
sites for 1251-labelled DTX have been detected in 
discrete areas of rat hippocampus and other brain 
regions [4]. 
Here, we report that a protein component of Mr 
-65000 on synaptosomal membranes, exhibiting 
high affinity for DTX, can be chemically cross- 
linked to 1251-labelled DTX. This facilitatory 
neurotoxin is thus shown for the first time to be an 
invaluable neurochemical probe for a protein that 
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is likely to comprise, or at least regulate, one type 
of K+ channel. 
2. MATERIALS AND METHODS 
2.1. Preparation of DTX 
The venom of D. angusticeps was obtained from 
Sigma and DTX was prepared as in [I 11, its 
homogeneity being ascertained by SDS- 
polyacrylamide gel electrophoresis (SDS-PAGE), 
on slab gels of 15% acrylamide, and by isoelectric 
focussing (pH 9-l 1) in gels of 5% acrylamide. The 
biological activity of the preparation was 
demonstrated by electrophysiological recording of 
its facilitatory action on neurotransmission in hip- 
pocampal slices 191; in addition, its toxicity was 
checked by intraventricular injection into rat brain 
(lethal dose of 2.5 rig/g body wt) [8]. 
2.2. Radioiodinat~on of DTX 
DTX was radiolabelled with “‘1 by a modifica- 
tion of the chloramine-T method [4] and was 
stored in the presence of 0.2% ethanol at 4°C. The 
specific activity of the 12’1-iodinated DTX (12’1- 
DTX) was determined by accurate measurement of 
protein content 171, using unlabelled DTX as stan- 
dard, and incorporated radioactivity; it was found 
to be 60-120 Ci/mmol for different batches. “‘I- 
DTX exhibited a level of neurotoxicity comparable 
[4] to that of native DTX. 
2.3. ~ynaptosoma~ preparations 
Synaptosomes were prepared from the cerebral 
cortex of rats (200-250 g) by density gradient cen- 
trifugation [7] and freeze-thawed prior to 
resuspension in Krebs-phosphate medium at 
5-6 mg protein/ml. Synaptic plasma membranes 
were made as in [12]; this involved lysing the crude 
mitochondrial pellet (P2) in 5 mM Tris-HCI buf- 
fer (pH 8.0) for 40 min at 5°C and isolating the 
membranes by flotation/sedimentation, using a 
3-step sucrose gradient. 
2.4. ~ea~rerne~t of i251-DTX birding to 
synaptosomes 
Synaptosomal suspensions (0.7-O-8 mg pro- 
tein/ml) in Krebs-phosphate medium (pH 7.4) 
were incubated for 45 min at 23°C in the presence 
of various concentrations (0.1-10 nM) of rz51- 
DTX (250~1 final volume). Aliquots (200 ~1) of 
the suspension were then removed and pipetted on 
top of 200~1 of a 45% (v/v) solution of dinonyl 
phthalate in Dow Corning MS-550 silicone fluid 
(oil). Bound “*I-DTX was separated from the free 
toxin by centrifugation at 8500 x g for 2 min. Ali- 
quots (100 al) were removed from the aqueous 
phase above the oil for determination of the free 
“‘I-DTX concentration at equilibrium. The re- 
mainder of the aqueous layer was then aspirated 
and the tubes were washed with 0.5 ml Krebs- 
phosphate buffer; the radioactivity remaining in 
the pellet was measured by y-counting to deter- 
mine the quantity of bound 12’I-DTX. Non- 
specific binding was measured similarly in the 
presence of a IOO-fold molar excess of DTX. For 
determination of protein concentrations 171 in 
these assays, triplicate synaptosomal suspensions 
were treated similarly to the test samples except for 
the omission of the oil in the centrifugation steps; 
the supernatant was aspirated and the pellet 
dissolved in 0.45 M NaOH. 
2.5. Cross-/inking of 1251-DTX to synaptic 
membranes 
Suspensions of synaptic plasma membranes 
(1.5-2 mg, 120 al), in Krebs phosphate buffer (pH 
7.4) contai~ng 1 mgfml bovine serum albumin, 
were incubated with ‘*‘I-DTX (2.5-10 nM final 
concentration) for 1 h at 23°C. Control samples 
were preincubated similarly but with the inclusion 
of excess DTX (1 /LM unless otherwise stated). The 
suspensions were centrifuged at 8500 x g for 2 min 
and the pellets washed at 4”C, once with 
phosphate-buffered saline (25 mM, pH 7.2) and 
twice with triethanolamine- HCl buffer (0.25 M, 
pH 8.5); finally, the samples were resuspended in 
1 mi of the latter buffer containing a series of con- 
centrations (0.05-5 mg/ml) of dimethyl suberimi- 
date (DMS) and incubated at 23°C for 2 h. After 
centrifugation, the p llets were washed with trie- 
thanolamine buffer (1 ml, twice) and suspended in 
50 mM sodium phosphate buffer (pH 8.0) con- 
taining protease inhibitors (1 mM EDTA, 0.1 mM 
ben~midine, OS mM phenylmethylsulphonyl 
fluoride, 10 Icg/ml soybean trypsin inhibitor, 
5 fig/ml bacitracin, 2 /rg/ml leupeptin) and 1% 
deoxycholate. The pellets were solubilised at 4°C 
overnight, centrifuged at 8500 x g for 5 min or 
200000 x g for 30 min and the supernatant was 
subjected to gel electrophoresis; the residual par- 
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ticulate fraction was further solubilised in 2% 
SDS/S% ,&mercaptoethanol and analysed 
similarly. 
2.6. Other methods 
SDS-polyacrylamide gel electrophoresis (SDS- 
PAGE) was performed [4] on slab gels of 
8% acrylamide. Protein content of membrane 
samples was determined by the Folin Lowry 
method, with bovine serum albumin as standard 
t71. 
3. RESULTS AND DISCUSSION 
A biologically active preparation [4,8] of lz51- 
DTX, labelled to high levels of specific radioactivi- 
ty, was found to bind saturably to a single set of 
non-interacting sites on freeze-thawed synap- 
tosomes (fig.1 inset) or synaptic membranes from 
rat cerebral cortex. Scatchard plots of the binding 
data (fig.1) revealed a site content of 
l-l .2 pmol/mg protein and a Kd of 0.43 nM (SD 
+ 0.07; n = 4); a Hill plot of the same data yielded 
a slope of unity. Heat treatment of synaptosomes 
or digestion with proteolytic enzymes abolished the 
binding of ‘*‘I-DTX, indicating that its acceptor 
contains a proteinaceous component [4]. 
Further characterization of this acceptor was 
achieved by covalently cross-linking it to ‘251- 
DTX. Under the conditions of labelling, the extent 
of specific DTX binding was high (70-90%); after 
treatment of these labelled membranes with DMS, 
practically all the bound radioactivity remained 
associated with the membrane pellet following 
overnight washing at 4°C. Extraction of the label- 
led, washed membranes with deoxycholate follow- 
3- 
0 
0 0.5 
1251-DTX bound (pmol mg-‘protein) 
Fig.1. Saturable binding of lz51-DTX to synaptosomes from rat brain. Synaptosome suspensions (0.7-0.8 mg 
protein/ml) in Krebs phosphate medium were incubated with “‘1-DTX (0.1-10 nM) for 45 min at 23°C. Aliquots of 
the suspension were then removed for the determination of free and bound radioactivity as described in section 2. Non- 
specific binding was determined in the presence of a lOO-fold molar excess of DTX. A Scatchard plot of the specific 
binding of “‘I-DTX is presented; the insert shows the saturation curve for the same experiment. Specific binding (0) 
was calculated as the difference between total binding (0) and non-specific binding (w) at equilibrium. Average values 
are plotted for duplicate determinations. Similar binding data were obtained with purified synaptic plasma membranes. 
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ed by electrophoresis and autoradiography 
resulted in the appearance of a polypeptide band 
of M, -72000 (fig.2A, tracks 2-5; B, tracks 2-4). 
This band was absent from control samples label- 
led in the presence of excess DTX (fig.2A,B, track 
I), indicating that the cross-linked protein is in- 
volved in the saturable binding of lz51-DTX. The 
same polypeptide was labelled using a range of 
concentrations of “‘1-DTX (2.5-10 nM) and 
DMS (0.05-5 mg/ml). Analysis of the residual 
radioactivity in the detergent-extracted membranes 
(the extent of this varied with the DMS concentra- 
tion used; with up to 1 mg/ml, it represented 
-50070 of the total) following dissolution of the 
pellet in SDS sample buffer containing & 
mercaptoethanol, gave a similar electrophoretic 
pattern. Likewise, when a different bifunctional 
A 
6 5 4 3 2 1 
reagent, dimethyl pimilimidate, was used under the 
same conditions a polypeptide of identical M, was 
labelled specifically (not shown). 
Under all the experimental conditions employed, 
a considerable quantity of specifically bound 1251- 
DTX was seen to migrate near the ion front 
(fig.2A,B). This low molecular mass band could 
not be attributed to free “‘1-DTX alone since in- 
significant amounts of radioactivity (less than 5% 
of the total) were removed on extensive washing 
(2 h at 23°C) of the cross-linked membranes, in- 
dicating that virtually all the toxin became irrever- 
sibly attached; dissociation from untreated mem- 
branes is, in contrast, relatively fast (ti,z -8 min at 
23°C). Rather, this band is believed to represent 
12’1-DTX which has become specifically cross- 
linked to low molecular mass material present in 
B 
Volume 174, number 1 FEBS LETTERS August 1984 
the membranes (e.g., lipid). Similar observations 
have been made in cross-linking studies on voltage- 
sensitive Na+ [ 1,13,14] or Ca’+-activated K+ chan- 
nels [15] and by authors in [la] who cross-linked 
12’I-&BuTX to its acceptor in chick brain mem- 
branes. Since the specific binding of “‘1-DTX is 
abolished completely by proteases and heating [4], 
the possibility of binding being solely to lipid 
moieties is unlikely; however, it is envisaged that 
when 1251-DTX is bound specifically to its protein 
acceptor, neighbouring lipid could become linked 
covalently to it. Consistent with this proposal, 
such labelling would be inhibited by excess DTX, 
as found experimentally (fig:2A,B). In view of the 
sensitivity of “‘I-DTX binding to phospholipolysis 
of the membrane (e.g., by bee venom 
phospholipase AZ) [4], it is plausible that lipid in- 
teraction is important in maintaining the acceptor 
in an active conformation. Such a role for lipid has 
been implicated also in the specific binding to 
neuronal membranes of &BuTX [4,7] and 
botulinum neurotoxin [ 171. 
An appreciable amount of specifically bound 
radioactivity failed to enter the gel, particularly 
when high DMS concentrations were used 
(fig.2A,B); hence, this high molecular mass 
material may have arisen from extensive cross- 
linking of the DTX oligomer. Radiation inactiva- 
tion of the DTX binding component in synap- 
tosomal membranes [4] has indicated that in the 
membrane-bound state this acceptor has a large 
molecular size (M,>200000); a similar conclusion 
was reached when deoxycholate extracts of synap- 
tosomal membranes, cross-linked to “‘1-DTX, 
were subjected to gel filtration (unpublished). 
Treatment of unlabelled membranes with 
C 
Fig.2. Autoradiogram of SDS-polyacrylamide gels of 
membranes cross-linked to “‘1-DTX. (A) Synaptic 
membranes were reacted with 7 nM rZSI-DTX in the 
absence (tracks 2-5) and presence (track 1) of 1 ,uM 
DTX, as described in section 2. After washing, the 
samples were cross-linked with DMS, washed and 
solubilised in 50 mM phosphate buffer (pH 8.0) 
containing anti-proteases and 1% deoxycholate. They 
were centrifuged at 8500 x g for 5 min and the 
supernatants ubjected to SDS-PAGE under reducing 
conditions on a polyacrylamide slab gel which was 
subsequently processed for autoradiography. The 
concentrations of DMS (mg/ml) used for cross-linking 
were: track 2, 0.05; 3, 0.1; 4, 2; 1 and 5, 5. (B) As in A 
except the membranes were labelled with 5 nM “‘I- 
DTX. The concentrations of DMS (mg/ml) used were: 
track 2,0.25; 3,0.5; 4, 1. As in A, a control sample was 
reacted with 1 mg/ml DMS (track 1). In both A (track 6) 
and B (track 5) standard proteins labelled with lz51 by 
the chloramine-T reaction were electrophoresed: these 
were thyroglobulin, Mr 330000; ferritin (half unit), Mr 
220000; phosphorylase b, Mr 94000; bovine serum 
albumin, Mr 67000; catalase, Mr 60000; ovalbumin, Mr 
43000; lactate dehydrogenase, Mr 36000. (C) 
SDS-PAGE of total protein (SDS extract) from brain 
membranes tained with Coomassie blue before (track 1) 
and after cross-linking as above with varying 
concentrations of DMS (mg/ml): track 2,0.1; 3,0.25; 4, 
0.5; 5, 1. 
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relatively high concentrations (0.5-l .O mg/ml) of 
DMS, followed by SDS-PAGE and staining with 
Coomassie blue, showed a change in the propor- 
tions of certain bands relative to those observed 
with non-crosslinked samples (fig.2C, tracks 
1,4,5). However, at lower DMS concentrations 
(co.5 mg/ml) no such changes were apparent 
(fig.2C, tracks 2,3) yet with this amount of cross- 
linking agent significant incorporation of lz51- 
DTX into the 72-kDa band was obtained (fig.2A, 
tracks 2,3; B, track 2). In fact, this was the smallest 
protein band seen at any concentration of DMS 
tested, indicating that it is the minimal size of pro- 
tein that can be cross-linked to DTX under the 
available experimental conditions. Therefore, it is 
unlikely that the 72-kDa component results from 
attachment of the DTX-acceptor subunit to other 
membrane polypeptides during the cross-linking 
reaction. Omission of reducing agent from the 
SDS gels (not shown) failed to produce an increase 
in the A4, of this labelled protein, demonstrating 
that it is not attached through disulphide bond(s) 
to other constituents of the acceptor oligomer (see 
above). 
Assuming the incorporation of 1 mol 12’1-DTX 
per mol polypeptide labelled, an M, of 65 000 is ob- 
tained for the free component. This is notably 
lighter than the 95-kDa polypeptide obtained by 
labelling chick brain membranes with 12’I-&BuTX 
[16] and it is, therefore, unlikely that the two com- 
ponents are identical although the possibility of 
species differences cannot be ruled out. Further- 
more, 50 nM ,&-BuTX was ineffective in reducing 
the binding [4] and/or cross-linking to the mem- 
branes of 2.5 nM ‘251-DTX; in contrast, 50 nM 
unlabelled DTX produced a large reduction in the 
extent of cross-linking seen. This is consistent with 
the interpretation that the DTX acceptor polypep- 
tide cross-linked in this study is not directly 
responsible for the high-affinity binding of fl- 
BuTX observed in rat synaptosomal membranes 
[7] and brain regions [18]. As expected, apamin, 
which inhibits the Ca2+-activated K+ channel in a 
number of tissues ([3], cf. [15]) and can be cross- 
linked to a protein of M, 28000 [ 151, is unable to 
affect the binding of ‘251-DTX to synaptosomes. 
In view of the reported attenuation by DTX of 
one type of voltage-sensitive K+-channel in hip- 
pocampus and its notable neurotoxicity in brain, it 
can be deduced that the binding component 
reported here is likely to be associated with or part 
of this K+-channel macromolecular complex. 
These cross-linking experiments represent he first 
direct identification of the DTX acceptor protein 
and are allowing the chemical nature of this func- 
tional component to be characterised further 
following its purification by immunoaffinity 
methods, using anti-DTX antibodies. 
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